U.S. Water Utilities Stock News

NasdaqCM:XPEL
NasdaqCM:XPELAuto Components

XPEL (XPEL) Q4 Results and 2026 Outlook Guidance Could Be A Game Changer For Earnings

XPEL, Inc. has reported past fourth-quarter 2025 results showing revenue of US$122.27 million and net income of US$13.41 million, alongside basic earnings per share from continuing operations of US$0.49. The company has also issued new guidance for first-quarter 2026 revenue of about US$112 million to US$114 million, giving investors a clearer view of near-term expectations. Now we’ll explore how this revenue guidance range shapes XPEL’s existing investment narrative and expectations for its...
NYSE:XPO
NYSE:XPOTransportation

Assessing XPO’s Valuation After AI Safety Rollout And Tariff Ruling Tailwinds

XPO (XPO) is in focus after rolling out AI tools that analyze dockworker photos to improve freight safety and reduce damage claims, while a Supreme Court tariff ruling could reshape cost dynamics for many of its shipping customers. See our latest analysis for XPO. XPO’s recent AI rollout and the tariff ruling arrive as momentum is already strong, with a 30 day share price return of 38.88% and a year to date share price return of 47.37%, alongside a 1 year total shareholder return of 67.51%...
NYSE:GPC
NYSE:GPCRetail Distributors

Is Genuine Parts (GPC) Now Attractively Priced After Recent Share Price Weakness

If you are wondering whether Genuine Parts shares are now attractively priced or still expensive, this article walks through what the current market price might be implying about the company's value. The stock recently closed at US$118.82, with a 5.5% decline over 7 days, a 13.7% decline over 30 days and a 4.2% decline year to date. The 1 year return is a 0.4% decline and the 3 year return is a 26.8% decline, compared to a 24.8% gain over 5 years. Recent news coverage has focused on Genuine...
NYSE:ELAN
NYSE:ELANPharmaceuticals

A Look At Elanco Animal Health’s Valuation After A Strong 1 Year Total Return

Recent performance snapshot Elanco Animal Health (ELAN) has caught investor attention after a strong 1 year total return of 146.5%, alongside positive moves over the past week, month and past 3 months. See our latest analysis for Elanco Animal Health. The current share price of US$26.38 sits against a 1 year total shareholder return of 146.5%, with recent 1 day and 30 day share price returns of 6.6% and 8.1%. This suggests that momentum remains strong rather than fading. If strong recent...
NYSE:GXO
NYSE:GXOLogistics

Assessing GXO Logistics (GXO) Valuation After Hunkemoller Automation Partnership And Robotics Expansion

GXO’s Hunkemoller partnership and tech rollout come into focus GXO Logistics (GXO) is in the spotlight after launching a multi-year partnership with Hunkemoller in Almere, where advanced automation supports a pan-European distribution network and expands GXO’s Flevoland logistics campus. See our latest analysis for GXO Logistics. These automation wins come as GXO’s 30 day share price return of 9.96% and 90 day share price return of 25.01% outpace its 16.26% year to date share price return,...
NYSE:AA
NYSE:AAMetals and Mining

Is It Too Late To Consider Alcoa (AA) After An 81% One Year Share Price Jump?

Investors may be wondering whether Alcoa at around US$61.41 a share is offering good value today, or if the easy gains are already behind it. The stock has returned 6.9% over the last 7 days, is roughly flat over 30 days with a 1.3% decline, and is showing gains of 8.6% year to date and 81.0% over the last year. This naturally raises questions about how the market is now pricing its risks and opportunities. Recent coverage of Alcoa has focused on its role as a major aluminum producer, with...
NYSE:KMX
NYSE:KMXSpecialty Retail

What CarMax (KMX)'s Leadership Shift to Ex-InterContinental CEO Means For Shareholders

CarMax has appointed former InterContinental Hotels Group CEO Keith Barr as its new Chief Executive Officer, President and Board member, effective March 16, 2026, with interim leader David McCreight returning to his role as independent director. Barr’s background in large-scale digital transformation, customer experience and brand-led growth in hospitality introduces a fresh cross-industry leadership approach to CarMax’s used-vehicle retail model. Next, we’ll examine how Barr’s digital and...
NYSE:WLY
NYSE:WLYMedia

A Look At Wiley (WLY) Valuation After Expanded Advanced Portfolio Journal Rollout

John Wiley & Sons (WLY) has drawn fresh attention after announcing a major expansion of its Advanced Portfolio, with eight new life, health, and social sciences journals planned by the end of 2026. See our latest analysis for John Wiley & Sons. At a share price of $29.35, John Wiley & Sons has experienced a 30 day share price return of a 5.6% decline and a 90 day share price return of an 18.49% decline, while its 1 year total shareholder return of a 23.77% decline suggests longer term...
NYSE:VICI
NYSE:VICISpecialized REITs

Is It Time To Reassess VICI Properties (VICI) After Recent Share Price Gains?

If you are wondering whether VICI Properties is offering good value at its current price, this article will walk through what the numbers actually say about the stock. Recently, VICI Properties closed at US$30.28, with returns of 1.4% over 7 days, 6.1% over 30 days, 7.6% year to date, 6.4% over 3 years, 38.0% over 5 years and a 1.7% decline over the last year. Investors have been watching VICI as it continues to feature in discussions around large scale experiential real estate and its role...
NYSE:FN
NYSE:FNElectronic

Fabrinet (FN) Is Up 17.9% After Surging AI Data Center Demand and Higher-Margin Pivot

In recent weeks, Fabrinet reported quarterly results and guidance that exceeded expectations, highlighting strong demand for its AI and data center–related optical manufacturing services and reinforcing its role as a key outsourced partner in these fast-growing hardware segments. The company also announced acquisitions and a pivot toward higher-margin business lines, while analyst upgrades and institutional interest highlighted Fabrinet’s improved positioning within the technology supply...
NYSE:V
NYSE:VDiversified Financial

Assessing Whether Visa (V) Looks Undervalued After Recent Share Price Weakness

Recent performance context for Visa (V) Visa (V) has recently drawn investor attention after a period of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, year to date, and past year. At a last close of US$307.22, Visa sits against a backdrop of multi year total returns, solid reported revenue of US$41.39b and net income of US$20.59b, as well as a value score of 3. See our latest analysis for Visa. Visa’s recent share price returns...
NasdaqGS:XP
NasdaqGS:XPCapital Markets

Is XP (XP) Using Its Shelf Offering to Redefine Growth and Capital Allocation Strategy?

In February 2026, XP Inc. filed a US$215.58 million shelf registration for 9,393,589 Class A shares after reporting fourth-quarter 2025 revenue of BRL 4,938 million and net income of BRL 1,282 million, both higher than a year earlier. The combination of year-on-year growth in revenue, earnings per share and client assets, alongside completion of a recent share buyback, underlines XP’s emphasis on scaling its platform while actively managing its capital structure. We’ll now examine how XP’s...
NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

Does AGNC’s (AGNC) Reaffirmed Monthly Dividend Reveal a Deeper Bet on Scale and Stability?

AGNC Investment Corp. recently declared a cash dividend of US$0.12 per common share for February 2026, payable on March 10 to shareholders of record as of February 27, while its 2025 10-K highlighted an Agency RMBS portfolio of US$94.80 billion and solid returns. This combination of continued monthly dividends and sizable, actively managed mortgage holdings underscores how AGNC is leaning on income stability and portfolio scale to support investor confidence. Next, we will examine how AGNC’s...
NYSE:SGI
NYSE:SGIConsumer Durables

Is It Too Late To Consider Somnigroup International (SGI) After A 5-Year 164% Return?

If you are wondering whether Somnigroup International at around US$88.62 is still good value after a strong run, you are not alone. This article focuses on what the current price could imply about the stock. The share price has returned 1.0% over the last 7 days, 37.2% over the past year and 112.9% over 3 years. The 30 day return of 4.4% and year to date return of 0.1% show that recent moves have been more muted. Recent news coverage around Somnigroup International has highlighted investor...
NasdaqGS:DXCM
NasdaqGS:DXCMMedical Equipment

Assessing DexCom (DXCM) Valuation After Short Term Gains And A 14.5% Undervaluation Narrative

Why DexCom Stock Is On Investors’ Radar DexCom (DXCM) has drawn fresh attention after recent trading left the shares near US$73, even as the stock shows mixed return patterns across the past week, month, past 3 months and year. See our latest analysis for DexCom. At around US$73, DexCom’s recent 7 day share price return of 3.78% and 90 day share price return of 16.89% contrasts with a 1 year total shareholder return decline of 17.24%. This suggests short term momentum while longer term...
NYSE:ALL
NYSE:ALLInsurance

Is Allstate (ALL) Still Attractive At Around US$210 After Strong Multi Year Gains?

Wondering if Allstate at around US$209.82 is still a sensible entry point, or if the easy gains are behind it? You are not alone in asking whether the current price lines up with the company’s underlying value. The stock has had a mixed short term patch, with a 1.2% decline over the last 7 days, an 8.4% gain over 30 days, a 2.9% return year to date, and a 12.3% return over the past year. The 3 year and 5 year returns stand at 73.6% and 114.8% respectively. Recent headlines around Allstate...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

Assessing NovoCure (NVCR) Valuation After British Columbia’s Reimbursement Breakthrough for TTFields Therapy

NouvoCure (NVCR) is back in focus after British Columbia agreed to fund its Tumor Treating Fields therapy for newly diagnosed glioblastoma, marking the first provincial reimbursement for this treatment in Canada. See our latest analysis for NovoCure. The British Columbia reimbursement news comes on top of February’s FDA approval of Optune Pax for locally advanced pancreatic cancer, and together these updates appear to have supported a 6.92% 1 day share price return and 5.48% 7 day share price...
NasdaqGS:UAL
NasdaqGS:UALAirlines

Will United’s New Co-Branded Card and Fleet Moves Reshape United Airlines Holdings' (UAL) Loyalty Narrative?

In recent days, Neo Financial and United Airlines announced a partnership to launch the United MileagePlus Neo World Elite Mastercard in Canada, alongside United’s plans to boost Lexington capacity, invest further in Brazil’s Azul, and equip upcoming 787 Dreamliners with 300 GEnx engines. Together, these moves highlight how United is trying to deepen customer loyalty, modernize its fleet, and strengthen its foothold in key international and regional markets. Next, we’ll assess how United’s...
NYSE:CLX
NYSE:CLXHousehold Products

What Clorox (CLX)'s Steady US$1.24 Dividend Amid Flat Sales Expectations Means For Shareholders

The Clorox Company recently declared a quarterly dividend of US$1.24 per share, payable on May 8, 2026, to shareholders of record as of April 22, 2026, underscoring continued cash returns despite a softer demand backdrop and flat near-term sales expectations. This steady payout, alongside management’s focus on innovation, ERP modernization and the GOJO acquisition, highlights an emphasis on operational stability and brand positioning even as category growth and competition remain...
NYSE:MP
NYSE:MPMetals and Mining

A Look At MP Materials (MP) Valuation As Rare Earth Prices Jump And DoD Support Increases

MP Materials (MP) is back in focus after rare earth prices, particularly neodymium praseodymium oxide, moved above U.S. subsidy thresholds. A fresh Department of Defense investment and new analyst coverage have also sharpened attention on the stock. See our latest analysis for MP Materials. After a sharp 16.01% 1 month share price decline, MP Materials has picked up again with a 4.92% 1 day share price return and 6.31% year to date share price return. Its 1 year total shareholder return of...
NasdaqGS:ULCC
NasdaqGS:ULCCAirlines

Assessing Frontier Group Holdings (ULCC) Valuation After Shelf Registration And Return To Annual Net Loss

Frontier Group Holdings (ULCC) has drawn fresh attention after filing a US$12.25 million shelf registration for 2,290,108 common shares tied to an ESOP offering, shortly after reporting a full year 2025 net loss. See our latest analysis for Frontier Group Holdings. The share price has moved sharply around these updates, with a 1-day share price return of a 4.92% decline and a 7-day share price return of a 13.27% decline. Over a longer period, the 90-day share price return is a 4.5% gain,...
NYSE:M
NYSE:MMultiline Retail

Assessing Macy's (M) Valuation After Recent Share Price Pullback

Why Macy's Stock Is on Investors' Radar Macy's (M) is drawing attention after recent share price swings, with the stock down about 2% over the past day and roughly 6% over the past week, despite a small gain over the past month. See our latest analysis for Macy's. Set against a weaker 90 day share price return of a 7.13% decline and an 8.44% decline year to date, Macy's 1 year total shareholder return of 49.99% shows how much dividends and previous gains have mattered, with recent momentum...
NYSE:AIG
NYSE:AIGInsurance

Will AIG's Earnings Beat, Bigger Buyback, and Dividend Hike Change American International Group's (AIG) Narrative

American International Group recently reported earnings that exceeded Wall Street expectations, unveiled a multi-billion-dollar share repurchase plan, and raised its US dollar dividend as part of its ongoing shift toward property, casualty, commercial, and specialty insurance while continuing to separate its life and retirement operations. This combination of an earnings beat, enhanced capital returns, and a clearer focus on core insurance lines reinforces AIG’s recovery and restructuring...
NYSE:LUMN
NYSE:LUMNTelecom

Is Lumen Technologies (LUMN) Still Appealing After Recent Share Price Pullback?

If you are wondering whether Lumen Technologies at around US$7.45 is a bargain or a value trap, you are not alone. The answer comes down to how you look at its valuation. The share price has pulled back recently, with a 7.9% decline over the last week and a 13.1% decline over the last month, even though the 1 year return sits at 67.8% and the 3 year return at 119.1%. These swings have kept Lumen on many investors' watchlists, as the market reassesses the balance between its long term...